DNMT3B and neoplasm: Using differential high resolution melting analysis, one study revealed that DNMT3B promoter methylation was linked to cancer type, tumor size, histologic grade, suggesting that DNMT3B promoting methylation could predict diagnostic and prognostic biomarker for breast cancer (Naghitorabi et al., 2013).